The Market for Minimally Invasive Medical Devices

Report Code: HLC051E

Publish Date: Mar 2009

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for MIS devices and instruments was worth $14.8 billion in 2008. This should reach $15.8 billion in 2009 and $23.0 billion in 2014, for a compound annual growth rate (CAGR) of 7.8%.
  • The U.S. has the largest share of the market, worth $8.9 billion in 2008 and an estimated $9.5 billion in 2009. This segment is expected to reach $13.6 billion in 2014.
  • Cardiothoracic surgery was the largest application segment for MIS devices and equipment in 2007, representing 70% of the total market. Cardiothoracic surgery was followed in order of size by orthopedic surgery (12%), gastrointestinal surgery (10%) and gynecology (3%).

INTRODUCTION

MINIMALLY INVASIVE SURGERY

Minimally invasive surgery is performed without making a major incision or opening, resulting in less trauma for the patient and yielding significant cost savings. These result from shorter hospitalization times and reduced therapy requirements. Other benefits of minimally invasive surgery are less pain, less need for postsurgical pain medication, less scarring, and less likelihood of complications related to the incision. 

Thus, minimally invasive surgery is defined either as based on the operative procedure (e.g., small incisions) or the outcome (reduced surgical complications or costs). However, minimally invasive is not the same as minor surgery. Some “minimally invasive” procedures, (e.g., coronary artery bypass surgery), still are major operations requiring a hospital stay.

In minimally invasive surgery, a miniature camera is introduced into the body through a small incision. It transmits images to a video monitor, enabling the physician to diagnose and, if necessary, treat a variety of conditions. To do this, the physician inserts surgical instruments and auxiliary devices, such as irrigation and drainage devices, through one or more small incisions.

Minimally invasive surgery shares some important characteristics, but should not be confused with either ambulatory (“walk-in”) or noninvasive surgery.

MINIMALLY INVASIVE VS. AMBULATORY SURGERY

Some types of minimally invasive surgery can be performed in an ambulatory (nonhospital) setting, but minimally invasive surgery is not necessarily identical with ambulatory surgery. Attempts to delineate minimally invasive from ambulatory surgery on the basis of incision size or use of an endoscope or other device to look inside the patient’s body run into too many exceptions to be very useful.

Perhaps the best way to distinguish minimally invasive surgery from other types of ambulatory surgery is to define it as surgery that, if performed using conventional open-incision techniques, requires hospital admission. This definition excludes such minor surgical procedures as vasectomies. These almost never are performed separately in a hospital setting.

MINIMALLY INVASIVE VS. NONINVASIVE SURGERY

In a sense, the ultimate in minimally invasive surgery does not require any incision or physical entry into the patient’s body. Examples include the use of ultrasound to break up gallstones and radiation to shrink or kill tumors. For purposes of this report, only those surgical procedures that involve physical access to the body through an incision or a natural orifice are considered minimally invasive surgery.

STUDY BACKGROUND

A growing number of surgical procedures are carried out using minimally invasive techniques. This has created a multibillion-dollar market for the specialized devices and instruments used for these procedures. They include monitors and imaging equipment, electrosurgical devices, handheld instruments, auxiliary devices and accessories. 

Because the use of these products is increasing so rapidly, there is a pressing need to develop an up-to-date base of market information to better understand the dynamics of the market for minimally invasive surgical devices and instruments. Nearly 3 years have passed since BCC Research published the previous edition of this study, Trends in the Noninvasive and Minimally Invasive Medical Device Market (HLC051D). It analyzed key growth areas, and developed quantitative market projections.

Since then, the market has continued to evolve. The population of the established markets is aging, bringing new surgical needs, while new markets are opening up. Technological advances have expanded the range of surgical procedures that can be performed using minimally invasive techniques, while giving physicians new tools for the diagnosis and treatment of injuries and pathologies. 

Meanwhile, the structure of the health care industry is changing, as traditional hospitals consolidate and other health care options become available to consumers. This study attempts to give management readers the information and analysis they need to deal with these challenges.

STUDY GOALS AND OBJECTIVES

This study meets these needs by analyzing global markets for minimally invasive surgical devices and instruments (see Scope and Format for a definition of these devices) in light of the most recent available information. In addition to looking at current and future markets, the study will analyze technological, demographic, and economic developments that may have a long-term impact on the size and structure of the market for minimally invasive devices and instruments.

This report also provides an analysis of the market for minimally invasive devices and instruments by type of surgical procedure, device, end user, and region. The future of minimally invasive surgical equipment also will be discussed, with forecasts for consumption of specific products. 

More specific objectives are to:

  • Identify and segment the main types of minimally invasive devices and instruments that have been commercialized to date
  • Analyze the historical and current volume and value of shipments of each of these product segments in specified end user and geographic markets
  • Identify and evaluate the impact of demographic, economic, and other factors that will drive future demand for minimally invasive devices
  • Forecast the volume and value of shipments of the product segments by the probabilities that future demand will be higher or lower than the baseline forecast
  • Identify promising new surgical procedures and products still in the development and testing stage, and assess the probability they will be commercialized successfully in the next 5 years
  • Forecast the potential market for these developmental procedures and products, taking into account the estimated probability they will be commercialized
  • Identify leading device manufacturers and analyze the structure of the minimally invasive surgical devices industry (e.g., market shares, concentration, and recent m&a activity)
  • Assess the long-term outlook for minimally invasive surgical devices, taking into account market opportunities, as well as technological, financial and economic factors.

INTENDED AUDIENCE

The report has been written for the minimally invasive surgical interest community, but is especially tailored for readers with an interest in the marketing and management dimensions of minimally invasive surgical devices and instruments. This especially includes readers in:

  • The medical and surgical devices industry
  • Medical research institutions
  • The investment community
  • The financial and analyst community
SCOPE OF REPORT
 
This report is an analytical business tool whose primary purpose is to describe the minimally invasive surgical devices industry and the U.S. market for these devices. The scope of the study does not include:
  • Devices and instruments used exclusively for traditional open surgical procedures (e.g., heart-lung machines)
  • Devices and equipment used exclusively in an ambulatory surgery setting
  • Equipment for nonsurgical types of therapy such as radiation therapy.

The format of the study is organized around the following topics: 

  • Major types and applications of minimally invasive surgical devices and instruments.
  • Industry structure.
  • Market size and segmentation, including historical data on sales by application, product type, end-user group and geographical market.
  • Market drivers.
  • Detailed market projections through 2014.
  • Competition and market shares.
  • Observations and conclusions regarding the future of minimally invasive surgical devices and instruments. 
METHODOLOGY AND INFORMATION SOURCES
 
The findings and conclusions of this report are based on information gathered from manufacturers and users of minimally invasive surgical devices, as well as other informed sources. Interview data were combined with information gathered from an extensive review of secondary sources, such as trade publications, trade associations, company literature and online databases, to produce the market estimates contained in this report. 
 
The base year for analysis and projection is 2008. At the time this report was prepared (early 2009), year-end data for 2008 were not yet universally available. Where necessary, market estimates for 2008 were developed using interim (partial) data for 2008, combined with historical data for 2007.
 
With 2008 as a baseline, market projections were developed for 2009 to 2014. These projections are based on a consensus of primary contacts combined with BCC Research’s understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.
 
All dollar projections presented in this report are in 2008 constant dollars. 
 
ANALYST CREDENTIALS
 
Andrew McWilliams is the author of this report. He is a partner in the Boston-based international technology and marketing consulting firm, 43rd Parallel LLC. Mr. McWilliams also is the author of several other BCC Research studies of the surgical and related health care markets. They include:
  • HLC038C     Patient Monitoring
  • HLC058A    Global Medical Markets for Nanoscale Materials and  
                       Devices
  • HLC054A     The Home Medical Equipment Market
  • HLC016C     Microelectronic Medical Implants: Products, Technologies 
                       and Opportunities
  • HLC045A     Prosthetics, Orthotics and Cosmetic Enhancement Products
  • HLC042A     Radiation-Based Therapy and Therapeutic Imaging
  • HLC036B     Medical Robotics and Computer Assisted Surgery Market
  • BIO022D     Organ and Tissue Transplantation and Alternatives
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of market research reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report, is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: The Market for Minimally Invasive Medical Devices151Free
Chapter- 1: INTRODUCTION6Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: OVERVIEW OF MINIMALLY INVASIVE SURGICAL DEVICES AND INSTRUMENTS53Free
Chapter- 4: MARKET FOR MIS DEVICES AND EQUIPMENT BY TYPE, APPLICATION SEGMENTS AND USER SEGMENTS48Free
Chapter- 5: INDUSTRY STRUCTURE, COMPETITION AND MARKET SHARES8Free
Chapter- 6: CONCLUSIONS: THE OUTLOOK FOR MINIMALLY INVASIVE SURGICAL DEVICES AND INSTRUMENTS 12Free
Chapter- 7: APPENDIX A: MINIMALLY INVASIVE SURGICAL PROCEDURES5Free
Chapter- 8: APPENDIX B: VENDOR PROFILES15Free
Chapter- 9: APPENDIX C: INDUSTRY AND PROFESSIONAL ORGANIZATIONS2Free
Published - Jun-2006| Analyst - Andrew McWilliams| Code - HLC051D

Report Highlights

  • The global market for minimally invasive surgery (MIS) devices and instruments was worth an estimated $12 billion in 2005, and is expected to reach $12.9 billion in 2006 and $18.5 billion by 2011, an average annual growth rate (AAGR) of 7.5% between 2006 and 2011. (These figures include catheters, balloons, stents and other devices used in minimally invasive angioplasty.)
  • The U.S. accounted for about 60% of the world market, or $7.2 billion in 2005, and is growing at an AAGR of 7.2%. The U.S. market should reach $7.7 billion in 2006 and $11.0 billion by 2011.
  • Surgical devices (e.g, stents, catheters, guidewires) are the largest product segment of the U.S. minimally invasive surgery market, of which they accounted for about a 69% share in 2005. Monitoring and visualization systems were the second largest segment of the U.S. market in 2005, with an 11% market share, followed by endosurgical instruments (10%), electrosurgical equipment (8%), and robotics (2%). Surgical robots are the fastest-growing equipment /device segment, with an AAGR of 12% between 2006 and 2011, followed by surgical devices, with an AAGR of 8%.
Published - May-2003| Analyst - Andrew McWilliams| Code - HLC051C

Report Highlights

  • Globally, the MIS devices market saw an average annual growth rate (AAGR) of 10% from 1999 to 2002.
  • By 2007, the market should rise to approximately $8.3 billion at an AAGR of 6.6%.
  • The U.S. market represents nearly 60% of the total world market.
  • Market drivers include demographics, epidemiology, new devices.
  • The lack of surgeons opting to train in MIS is a potential constraint on the market.

Related Reports

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

World Markets for Fermentation Ingredients

Published - Nov 2022 | Publisher - BCC Publishing | Code - FOD020G

The global fermentation-derived fine chemicals market should reach $42.4 billion by 2027 from $32.0 billion in 2022 at a compound annual growth rate (CAGR) of 5.8% for the forecast period of 2022 to 2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
The Market for Minimally Invasive Medical Devices
Customize Report